COGT P/E Ratio
P/E Ratio as of Oct 28, 2025: -6.64
Average-6.43
Median-6.52
Minimum-6.84
Maximum-5.83
-6.64
Past Month-0.80 (13.70%)
The P/E ratio for COGT is -6.64 as of Oct 28, 2025. This represents a increase of 81.92% compared to its 12-month average P/E ratio of -3.65. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cogent Biosciences, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cogent Biosciences, Inc. ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cogent Biosciences, Inc. to industry peers.
Cogent Biosciences, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cogent Biosciences, Inc. ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cogent Biosciences, Inc. to industry peers.
COGT P/E Ratio Insights
See Cogent Biosciences, Inc. ’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in COGT
Order type
Buy in
Order amount
Est. shares
0 shares
COGT P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $14.13 | -5.83 |
| Sep 2, 2025 | $12.00 | -4.95 |
| Aug 1, 2025 | $11.40 | -4.8 |
| Jul 1, 2025 | $7.22 | -3.04 |
| Jun 2, 2025 | $5.61 | -2.36 |
| May 1, 2025 | $5.63 | -2.28 |
| Apr 1, 2025 | $5.79 | -2.35 |
| Mar 3, 2025 | $7.00 | -2.84 |
| Feb 3, 2025 | $8.99 | -3.63 |
| Jan 2, 2025 | $7.80 | -3.15 |
COGT End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -6.64 | +110.79% |
| 2024 | -3.15 | +25.50% |
| 2023 | -2.51 | -45.67% |
| 2022 | -4.62 | 0.00% |
| 2021 | -4.62 | +431.03% |
| 2020 | -0.87 | — |
FAQs About Cogent Biosciences, Inc. (COGT) P/E ratio
The latest P/E ratio of COGT is -6.64, as of Oct 28, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Cogent Biosciences, Inc. ’s last 12-month average P/E ratio is -3.65, compared to its current P/E ratio of -6.64. This reflects a increase of 81.92%.
Cogent Biosciences, Inc. ’s current P/E ratio of -6.64 is higher than its last 12-month average P/E of -3.65. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cogent Biosciences, Inc. ’s average P/E ratio over the last 3 years is -4.05. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cogent Biosciences, Inc. ’s average P/E ratio over the last 5 years is -3.34. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.